Black Diamond Therapeutics (BDTX) Earnings Date, Estimates & Call Transcripts $3.13 -0.08 (-2.49%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$3.21 +0.08 (+2.68%) As of 07/18/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Black Diamond Therapeutics Earnings Summary Black Diamond Therapeutics issued Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.28, which beat the consensus estimate of -$0.31 by $0.03. With a trailing EPS of $0.06 and a P/E Ratio of 52.17, Black Diamond Therapeutics' earnings are expected to grow next year, from ($1.30) to ($1.22) per share. Upcoming Earnings DateAug. 5Before Market OpensEstimatedConsensus EPS (Mar. 6) -$0.31 Actual EPS (Mar. 6) -$0.28 Beat By $0.03 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)BDTX Upcoming EarningsBlack Diamond Therapeutics' Q2 2025 earnings is scheduled for Tuesday, August 5, 2025, with a conference call scheduled on Wednesday, August 6, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Black Diamond Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Black Diamond Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBDTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Black Diamond Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.32$0.92$0.30Q2 20252-$0.33-$0.25-$0.29Q3 20252-$0.33-$0.25-$0.29Q4 20252-$0.34-$0.19-$0.27 FY 2025 8 -$1.32 $0.23 -$0.55 Q1 20261-$0.22-$0.22-$0.22Q2 20261-$0.23-$0.23-$0.23Q3 20261-$0.23-$0.23-$0.23Q4 20261-$0.24-$0.24-$0.24 Black Diamond Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)--------3/6/2025Q4 2024-$0.31-$0.28+$0.03-$0.28--11/5/2024--$0.37-$0.28+$0.09-$0.28--8/6/2024Q2 2024-$0.39-$0.36+$0.03-$0.36--5/9/2024Q1 2024-$0.44-$0.35+$0.09-$0.35--3/12/2024Q4 2023-$0.47-$0.34+$0.13-$0.34--11/6/2023Q3 2023-$0.49-$0.45+$0.04-$0.45--8/11/2023Q2 2023-$0.54-$0.52+$0.02-$0.52-- Black Diamond Therapeutics Earnings - Frequently Asked Questions When is Black Diamond Therapeutics' earnings date? Black Diamond Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on BDTX's earnings history. Did Black Diamond Therapeutics beat their earnings estimates last quarter? In the previous quarter, Black Diamond Therapeutics (NASDAQ:BDTX) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.03. Learn more on analysts' earnings estimate vs. BDTX's actual earnings. How much profit does Black Diamond Therapeutics generate each year? Black Diamond Therapeutics (NASDAQ:BDTX) has a recorded net income of -$69.68 million. BDTX has generated $0.06 earnings per share over the last four quarters. What is Black Diamond Therapeutics' price-to-earnings ratio? Black Diamond Therapeutics (NASDAQ:BDTX) has a trailing price-to-earnings ratio of 52.17. What is Black Diamond Therapeutics' EPS forecast for next year? Black Diamond Therapeutics' earnings are expected to grow from ($1.30) per share to ($1.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Urogen Pharma Earnings Results Tilray Brands Earnings Results Tango Therapeutics Earnings Results Stoke Therapeutics Earnings Results Prime Medicine Earnings Results Dianthus Therapeutics Earnings Results Phathom Pharmaceuticals Earnings Results Upstream Bio Earnings Results Xencor Earnings Results Mind Medicine (MindMed) Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Netflix Q2 2025 Earnings: What Investors Need to KnowHow Goldman Sachs Earnings Help You Strategize Your PortfolioCitigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings Report This page (NASDAQ:BDTX) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDTX Stock Alerts